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years. HRT slope was calculated from the first twenty beats. Fractal scaling coefficients, 
c¢, were computed using a dstrended fluctuation analysis of the first thirty beats. The 
degree of prematudty was defined as the ratio of the RR interval of the premature beat to 
that of the preceding interval. 
Results: A total of 227 PACs and 171 PVCs were analyzed from 24-hour Hollers. The 
HRT slope (mean ±SE) was 17+ 1 ms/beat for PACs and 26± 2 ms/beat for PVCs 
(p<0.001). There was a negative correlation between HRT slope and degree of prematu- 
rity (r=-0.4, p<O.001), which was present for PVCs and PACs analyzed as separate 
groups. Following PACs, C¢FAC = 1.16±0.02 and following PVCs, CCpv c = 1.19 ±0.03 
(p=NS), and showed a small positive correlation for degree of prematudty of PVCs 
(r=0.2, p<0.001), but not for PACs. 
Concluelons: In normal subjects, HRT slope differs for PACs and PVCs and correlates 
with prematudty. The frectal properties of this variation are unaffected by the type of beat 
but are dependent on the degree of prematudty of PVCs. By taking into account the pre- 
maturity of the PVC and combining with a frectal scaling analysis, risk stratification may 
be enhanced. 
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1114-111 Epicerdlal Radiofrequency Ablat ion of Ventricular 
Myocardlum: Mechanisms of Lesion Formation and 
Damage to Adjacent Structures 
Guilherme Feneion, Kleber Ponzi, Angelo de Paoia, Paulista School of Medicine, S~o 
Paulo, Brazil. 
Background: Epicardial radiofrequency (RF) ablation has been increasingly used in 
patients with ventricular tachycardia, but the mechanisms of epicardial esion formation 
are not well understood. 
Methods: In 23 dogs (16-25 Kg), we compared epicardial (Epi, n=7) versus endocardial 
ventricular ablation (Endo, n=7) using fluoroscopy-guided, standard techniques (70°C/60 
sac, 50 W). Further, epicardial RF delivery was assessed during catheter tip irrigation 
(n=3) and with a holder to assure optimal electrode-tissue contact (n=6). In the latter, 
thermally-insulated (TI) electrodes (50% tip surface) were also used (n=3). In the Endo 
group, percutaneous techniques were used. In the Epi group, a minithoraootomy was 
made and a sheath was placed in the pedcardial space. 
Results: Power (16 vs 11 W), catheter tip temperature (68 vs 67°C) and impedance (157 
vs 165 Ohms) during RF delivery, and lesion dimensions were similar in Epi and Endo 
groups. In Endo, 11/31 (35%) lesions were transmural, compared to 0/25 (0%) in Epi 
(p<0,001). With optimal electrode-tissue contact, power outputs (4 vs 16 W; p<0,001) 
and pacing thresholds (0.2 vs 3.7 mA; p=0,004) were lower than Epi, However, lesion 
dimensions were similar and transmural lesions did not occur (depth 3.0±1.5 ram). Cath- 
eter irrigation (13 mlJmin) allowed delivery of high power outputs (42 W; 40°C) and con- 
sistently produced transmural lesions, 5/11 (55%), depth 6.5±2.1 ram. At constant power 
(2W), catheter-tip temperature (52 vs 57°C; p=NS) and lesion dimensions were similar 
for conventional and TI electrodes. However, damage to parietal pericardium and lungs 
occurred with conventional electrodes only. RF delivery directly to these structures with- 
out contacting the epicardium was not possible due to high impedance. 
Conclusion: Conventional epicardial RF ablation is not capable of producing deep, trans- 
mural lesions and is associated with a significant energy loss due to poor electrode-tis- 
sue contact. The lack of cooling effect limits power delivery in the pei'icardial apace. 
Damage to adjacent structures results from passive heat conduction from catheter tip 
and not from resistive heating of tissue. TI electrodes may prevent damage to these 
structures. 
1114-112 Epicardial Ablation of Vantrlcular Techycardia: Location 
of Successful Ablation Site and Long-Term Follow-Up 
Nassir F, Marrouche, Robert Schweikert, Walid Saliba, Christopher Cole, Andrea Natale. 
Cleveland Clinic, Cleveland, Ohio. 
Background: We describe results and location of epicardial ablation to treat ventdcular 
tachycardia refractory to endocardial ablation. 
Methods and Results: Nineteen patients (mean age 46.+.21 years, 16 men) presented 
for epicardial mapping and ablation of monomorphic VT. Of these 19 V'l's, 17 appeared to 
originate from the epicardium. Of these 17 patients, 5 had coronary cardiomyopathy, 1
had idiopathic ardiomyopathy, and 11 had normal hearts. Twelve of these patients were 
successfully ablated with epicardial esions after endocardial esions both with 4 mm tip 
and cooiod-tip catheters were delivered without effect. The location of the successful 
ablation sites in all 12 patients was along the main branches of the coronary arteries. 
After a mean follow-up of 13+5 months no recurrence of VT was observed. One patient 
had transient symptoms of pericarditis that resolved quickly within 48 hours with nonste- 
roidal anti-inflammatory agent. No other complications were observed. 
Conclusion: In our preliminary experience epicardial mapping and ablation of VT is safe 
and feasible. The majority of successful ablation sites appeared located along the epicar- 
dial course of the coronary arteries. 
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1114-113 Is Noncontact Mapping Associated With a Higher 
Complicat ion Rate Than Conventional Mapping in 
Catheter Ablat ion of Complex Arrhythmlas? 
Kadheinz Seidt, Monika Rameken, Margit Vater, Harald Schwacke, Andreas Brandt. 
Jochen Senges, Heart Center, Ludwigshafen, Germany. 
Non-Contact Mapping (NCM) permits high density endocardial mapping of arrhythmias. Its 
usefulness for mapping of complex arrhythmias to guide catheter ablation has been dem- 
onstrated. Aim of this study was 1) to evaluate the safety of NCM in 108 patients (pts) in 
whom catheter ablation was guided by NCM, 2) to compare the complication (C) rate of 
catheter ablation guided by NCM with the C rate observed with conventional mapping (CM) 
in 213 pts. Catheter ablation was performed in 321 consecutive pts with complex arrhyth- 
mias (55 ectopic atdal tachycardias, 104 atrial flutter, 19 atrial fibrillation, 75 ventdcular 
tachycardia, 68 ventricular ectopy). CM was performed in the first 213 pts, NCM was used 
in the following 108 consecutive pts. All perioperative C (< 4 weeks) were registered. Main 
C categories are listed below. Using a logistic regression model determinants which were 
associated with a higher C rate were evaluated (adjusted to clinical and procedure param- 
eters). The only independent predictor which was associated with a higher C rate was an 
impaired left ventdcular function with ejection fraction <40% (OR 4, CI 1.08 - 14,8). NCM 
was not associated with more C (OR 0.56, CI 0.17 - 1.81). Conclusion: The C rate in cath- 
eter ablation with NCM was 9,3% compared to 6.6% with conventional mapping. Using a 
logistic regression model NCM was not associated with a higher C rete.The only indepen- 
dent risk factor associated with a higher C rate was an impaired left ventdcular function. 
Complications (C): Comparison CM vs NCM 
CM NCM P-Value 
Pericardial effusion 4 pts (1.9%) 3 pts (2.8%) 0.69 
Thromboembolic C 4 pts (1.9%) 2 pts (1,9%) 0.45 
Vascular C 5 pts (2.3%) 4 pts (3.7%) 0,49 
Other C 1 pt (0.5%) 1 pt (0.9%) 1 
C total 14 pts (6.6%) 10 pts (9.3%) 0.38 
1114-114 Differential 12 Lead Electrocardiographic 
Manifestations of Arrhythmogenic Right Ventricular 
Dysplasla Versus Right Ventricular Outflow Tract 
Ventricular Tachycardias 
K. L. Venkatachalam. Douglas L. Packer, Mayo Foundation, Rochester, Minnesota. 
Background: The differential diagnosis for left bundle/inferior axis right ventricular tachy- 
cardia (VT) includes arrhythmogenic right ventricular dysplasia (ARVD) and idiopathic 
right ventdcular outflow tract (RVOT) ventdcuiar tachycardia. Since they are due to differ- 
ent mechanisms, it should be possible to distinguish between the two conditions using 
the 12-lead ECG during spontaneous VT. 
Methods: Nine patients with a definite diagnosis of ARVD and eighteen patients with 
RVOT VT were identified from the Mayo Foundation database. Patient age for the ARVD 
group was 43 + 22 years and for the RVOT group was 45 ± 27 years. None of the ARVD 
patients had underlying heart disease, In the RVOT group, one patient had hypertension, 
one had coronary artery disease and two had mitral valve prolapse. 12-1eed ECGs of 
spontaneous left bundle ventdcular tachycardias were analyzed for over 60 parameters 
including gross morphology, amplitudes, duration of Q to S nadir, transition points and 
the presence of notching. 
Results: There were significant differences (using Fisher's Exact Test and 2-tailed p val- 
ues) in the 12-1eed VT ECGs between the two groups. 9/9 (100%) ARVD patients had 
onset of Q to nadir of S duration (Lead V1 or V2) equal or greater than 80 msec versus 7/ 
18 (39%) RVOT patients (p = 0.003), 17/18 (94%) RVOT patients had deep S waves 
(lead aVL) versus 3/9 (33%) ARVD patients (p = 0.0017). 9/9 (100%) ARVD patients had 
QRS duration (Lead V1 or V2) equal or greater than 140 msec versus 6/18 (33%) RVOT 
patients (p = 0,0027). 11/18 (61%) RVOT patients had deep S waves (Lead I) versus 0/9 
(0%) ARVD patients (p = 0.003). 7/9 (78%) ARVD patients had R-wave notching (Lead I) 
versus 5/18 (28%) RVOT patients (p = 0.037). 
Conclusion: The 12-lead ECG of VT in ARVD is significantly different from that of RVOT. 
Specific characteristics of the 12-lead ECG in VT discriminate between ARVD and RVOT 
VT. This information may be useful in determining the underlying disease process to 
reduce the risk of misclassifying ARVD as benign RVOT VT. 
1114-115 Is Catheter Ablation of Hemodynamical ly  Unstable 
Ventricular Techycardia Feasible Using Noncontact 
Mapping? 
Karlheinz Ssidl, Monika Rameken, Margit Vater, Harald Schwacke, Andreas Brendt, 
Jochen Sengas, Heart Center, Ludwigshafen, Germany. 
Hemodynamic collapse precludes extensive catheter mapping to identify the target 
region in patients with ventricular tachycardia (VT) with conventional sequential catheter 
mapping. However, the non-contact mapping system (NCM) computes virtual electro- 
grams simultaneously at more than 3000 ventricular sites, A single beat of the VT seems 
to be sufficient o map the VT. The purpose of this study was to assess the clinical utility 
of NCM for mapping and ablating unstable VT. Methods: We evaluated 29 patients (pts) 
with an implantable cardioverter defibrillator (ICD) with drug refractory monomorphic and 
hemodynamic unstable v r  (24 pts had ischemic VT and 5 pts had nonischemic vr, ejec- 
tion fraction 33±15%). All pts had experienced at least • 2 episodes of unstable VT 
(mean cycle length 295±75 ms) during the month before treatment. Catheter ablation 
was performed with a linear lesion at the diastolic pathway just before the exit site. 
Rediofrequency energy was delivered dudng sinus rhythm and efficacy was assessed by 
programmed ventricular stimulation. All pts had a regular follow up in our ICD clinic 
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(median follow up 243 days), Results: NCM identified the exit site of the V]- and an early 
diastolic pathway in all pts. Mid-diastolic or presystolic potentials were found in 11 pts 
(38%). Acute success of catheter ablation was achieved in 20 of the 29 VT (69%). No 
complication was observed. During follow up 5 pta had a recurrence of VT, resulting in an 
overall success in 15 of 29 pts (52%). Conclusion: NCM may expand the indication for 
radiofrequency catheter ablation of VT by allowing catheter mapping of hemodynamic 
unstable VT. The acute success rate is 69%, the long term success 52%. 
1114-116 Radiofrequency Catheter Ablation of Ventricular 
Tachycardia Using a Virtual Dynamic 3-D Endocardial 
Mapping System Based on Sonomicrometry 
Alida E. Boroer van der Buro. Natasja M S. de Groot, Marianne Bootsrna, Lieselot van 
Erven, Ernst E. van der Wall, Martin J. Schalij, Leiden University Medical Center, Leiden, 
The Netherlands. 
Introduction: Radiofrequency catheter ablation (RFCA) is a potentially curative treatment 
option of ventricular tachycardia (VT). Endocardial mapping is mandatory to identify tar- 
get sites for ablation. Fluoroscopy guided RFCA however, is often long-lasting and might 
be inaccurate. We studied the efficacy of the use of a new 3-D mapping system with a 
deformable heart model based on the real-time position management (RPM) system. 
Methods: The RPM system uses sonomicrometry for exact Iocalisation of the catheters in 
a 3-D space. Two reference catheters form a frame in which the position of the ablation 
catheter can be determined. The heart model appears as a spherical body which 
expands to the real endocardial contour by dragging the ablation catheter along the wall. 
The local activation times are color-coded and superimposed over the model. 
Results: Twenty-five pts (20 mate, 61±16 yrs) with drug refractory VT underwent RFCA 
with this system. The underlying etiologies were: ischemic heart disease:16 (IHD, 64%), 
arrhythmogenic right ventricular cardiomyopathy:4 (ARVC, 16%) and idiopathic VT:5 
(IDIO, 20%). Three pts survived an OHCA (all IHD). During the procedure 64 VT mor- 
phologies (2.6 ± 1.7/pt, CL 320±81 ms) were induced and targeted for ablation. The pro- 
cedure was successful in 80% (20/25) of the pts: IHD 75%, ARVC 75%, IDIO 100%. 
Procedure and fluoroscopy times were 174±66 rain and 41±23 min respectively. Compli- 
cations were observed in two pts (8%). Myocardial wall perforation occurred in an ARVC 
pt dudng RF application. Although immediate surgery was performed, the pt died due to 
cardiogenic shock. The other pt suffered from a complete heart block. Before discharge, 
seven pts (29%, 3 pts with OHCA included) underwent ICD implantation because of a 
non-successful ablation and/or hemodynamically non- tolerable VTNE During follow-up 
(4.6±4.4 mths) 4 pts (17%) suffered from a recurrence of VT. Most recurrence were 
observed in the non-successful ablated pts (p=0.05). 
Conclusion: RFCA of VT with the new RPM system is successful (80%) and relatively 
safe. Recurrences were observed in 17% of the pts. Ultimately, the use of this system 
might result in an important reduction in fluoroscopy and procedure times. 
POSTER SESSION 
1115 Newer Techniques in Pacing and 
Defibrillation 
Monday, March 18, 2002, Noon-2:00 p.m. 
Georgia World Congress Center, Hall G 
Presentation Hour: 1:00 p.m.-2:00 p.m. 
1115-106 The Effects of Dofetilide on Patients With Atrial 
Arrhythmlas and Implantable Electrophysiology 
Devices 
Nour M. Juratii, Janet Searker, Khaldoun Soudan, Jererny Weedon, Bruce L Wilkoff, 
Patrick J. Tchou, Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Antiarrhythrnic drugs (AAD) are frequently prescribed to patients with pece- 
maker (PM) or implantable cardioverter defibrillator (ICD). It is known that these drugs 
have different effects on pacing, sensing, and defibrillation thresholds (DFT). The avail- 
ability of mode switching capability in most PMs and ICDs allows better assessment of 
the efficacy of these drugs on atrial arrhythrnias (AT). We intended to study the effects of 
the new class III AAD dofetilide on pacing and sensing thresholds and on AT control. 
Methods: Between 5/00 and 7/01 231 patients with AT were treated with dofetilide. 
Irnplantable electrophysiologic devices (EPD) were present in 54 (23%) pts (PM in 32, 
single-chamber ICD in 5, dual-chamber ICD in 17 pts). The mean daily dose of dofetilide 
was 676_+ 294 rncg. Values of pacing and sensing threshold were obtained by using the 
nearest visit to PM clinic pre and post initiation of dofetitide. Slope was calculated by 
extracting the pra value from the post value divided by time interval in days. Patients 
were excluded if they were started on dofetilide before or within 6 weeks of EPD implan- 
tation. Mode switching episodes were recorded during subsequent visits to PM clinic 
after dofetilide initiation. Results: The median slope was not significantly different from 
zero in pacing and sensing thresholds for atrial and ventricular leads. In 11 pts who were 
treated with 1000 mcg daily of dofetilide the median daily slope was -0.0114 rnv. Higher 
doses of dofetilide had only decreased the median slope for ventricular sensing 
(p=0.036) with no significant effects on other threshold values. Post dofetilide DFT was 
<10 joules in 3 pts and <20 joules in one patient. Two patients had appropriate ICD 
shocks and the remaining ICD pts had no evidence of ICD malfunction. Out of 34 pts with 
mode switching information 23(68%) had evidence of recurrent AT over a median follow- 
up of 59 days. Conclusions: 1 ) Dofetilide has no clinically significant effects on pacing or 
sensing thresholds. 2) Patients with marginal ventricurar sensing thresholds should be 
monitored closely during treatment with high doses of dofetilide. 3) Early recurrence of 
atnal arrhythmias is common in this group of patients. 
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1115-107 Incremental Programming of Atrial Antitachycardia 
Pacing Therapies Increases Therapy Efficacy: Results 
of the European AT500 Verification Study 
Burkhard Huol. Chdstina Unterberg, Carsten Israel, Thomas Lawo, Ingdd Kennis, 
Douglas Hettrick, Heart Center Leipzig, Leipzig, Germany, Medtronic, Inc, Minneapolis, 
Minnesota. 
INTRODUCTION: The impact of device programming of atrial anti-tachycardia pacing ther- 
apies (ATP) on termination efficacy is unknown. We tested the hypothesis that more 
aggressive ATP programming increases the probability of terminating atrial tachyarrhyth- 
mias (AT). 
METHODS: ATP efficacy was evaluated in 61 patients (pts), 39 male; age 66±10 yr, partic- 
ipating in a prospective, multicentar study of 340 pts with a Class 1/11 (AHNACC) indication 
for pacing. Most pts (95%) also had a history of AT. Mean LVEF was 55±16% and 6 pts 
(10%) were NYHA class II1. Each pt was implanted with a DDDRP pacing system 
(Medtronic AT500TM). This device is capable of treating AT with ATP. ATP termination effi- 
cacy and AT frequency / burden were compared within each pt dudng periods of nominal 
device programming (NP) vs. later periods of more aggressive programming (AP). NP 
included up to 18 sequences of ATP treatment for regular AT episodes longer than 1 min, 
atdal cycle length of 220-360 ms. AP included any programming that widened the detection 
zone (e.g. 150-360ms) and/or increased the maximum number of sequences above 18. 
RESULTS: 49 of the 61 pts experienced at least one AT episode dudng either period. Of 
these, 6 pts expedenced only untreated episodes due to high rate or irregularity (i.e. atdal 
fibrillation). 36 pts experienced 3407 treated episodes over a follow-up period of 67±37 
days dudng the NP period. 42 pts experienced 10,162 treated episodes over a follow-up of 
117±66 days dudng the AP pedod. Treated episodes were not different in episode duration 
or atrial cycle length during either periods. ATP termination efficacy was higher during AP 
than dudng NP (64 vs. 42%, p<0.05). Also, the ratio of treated to untreated episodes was 
higher during AP than during NP (0.97 vs. 0.32). No differences in AT frequency (3.3±5.9 
vs. 3.2±6.9 day-t) or burden (18±28 vs. 18±29%) were observed during NP and AP. 
CONCLUSION: Incremental programming increases the number of treated AT episodes 
and device classified ATP efficacy. Such programming did not lead to further reduction in 
AT frequency or burden. 
1115-108 Interatrial Septum Pacing Guided by Three-Dimensional 
Intracardiac Echocardiography 
Tarnas Szili-Torok. Marcoen Scholten, Jurgen Ligtharf, Gerardus Kirnman, Nice Bruining, 
Jos Roelandt, Luc Jordaens, Thoraxcenter, EMCR, Rotterdam, The Netherlands. 
Background: Interatdal septurn (IAS) pacing may be beneficial for patients with paroxys- 
mal atrial fibrillation. Currently, the IAS pacing site is selected indirectly by fluoroscopy 
and P-wave analysis. The aim of the present study was to develop a novel approach for 
IAS pacing based on intracardiec echocardiography (ICE, Boston Scientific). 
Methods: The ICE transducer is positioned into the superior vena cava (SVC) and pulled 
back into the inferior vena cave by an ECG- and respiration-gated and triggered tech- 
nique. The right- and left atria are then three-dimensionally (3D) reconstructed (TomTec). 
Using an "en face" view of the IAS the desired pacing site is selected. The selected spot 
serves as a reference point for creating a horizontal two-dirnensional (2D) template. 
Real-time, 2D ICE is then used to guide implantation of the atrial pacing lead. After lead 
placament and electrical testing another 3D reconstruction is performed to verify the final 
lead position. Measurements and assessment of P-wave duration are performed off-line. 
Results: A total of 8 patients were included into this feasibility study. IAS pacing was 
achieved in all patients including 4 suprafossal (SF) and 4 infrafossal (IF) lead locations 
confirmed by the 3D-reconstruction approach. The mean duration of the atrial lead 
implantation time and fluoroscopy time were 46.6±30.6rain and 12.9±9.1 rain, respec- 
tively. IAS pacing resulted in a significant reduction of the P-wave duration as compared 
to sinus rhythm (53.2 ms vs. 129.4 ms; p<0.0001). SF pacing showed a greater reduction 
of the P-wave duration than IF pacing (65.6ms vs. 31.5 ms). 
Conclusions: 1, Three-dimensional ICE is a feasible approach for guiding IAS pacing. 2, 
3D ICE allows selection of the optimal anatomical pacing site with the shortest P-wave 
duration. 3, Our data suggest that SF pacing is the preferable method for pacing the IAS. 
1115-109 Percutaneous Treatment for Pacemaker Lead-Related 
SVC Syndrome 
Albert W. Chan. Deepak L. Bhatt, Bruce L. Wilkoff, Marco Roffi, Debabrata Mukherjee, 
Bruce H. Gray, Christopher T. Bajzer, Jay S. Yadav, The Cleveland Clinic Foundation, 
Cleveland, Ohio, University of Michigan, Ann Arbor, Michigan. 
Background: Superior vena cava (SVC) obstruction is an uncommon but sedous compli- 
cation associated with permanent ransvenous pacemaker leads. Surgical removal and ra- 
implantation of pacing leads, and venous re-construction have been the standard treat- 
ment. We report our initial experience with a percutaneous approach to this problem. Meth- 
ods: Coordinated by the cardiac electrophysiologist and the interventional cardiologist, the 
old permanent pacemaker leads were extracted with an excimer laser sheath with constant 
application of countertraction on the pacemaker leads. Subsequently, transvenous angio- 
plasty and implantation of self-expanding nitinol stent(s) were performed at the site of 
obstruction. New pacemaker leads were then re-implanted through the reconstructed vein. 
Patients were discharged the next day if they remained stable during overnight observa- 
tion. Results: Between 09/2000 and 06/2001,4 patients (age 24-49 years; 2 females) pre- 
sented with SVC syndrome at a median 14 years (range 6-17 years) after pacemaker 
implantation. All patients underwent successful lead extraction and percutaneous revascu- 
larization. Except for one patient who had severe tricuspid regurgitation due to ruptured 
chordae and later underwent surgical epicardial pacemaker implantation, all had success- 
ful re-implantation of the transvenous pacemaker system. On clinical follow-up (2-11 
months), all patients were free of obstructive symptoms. Conclusions: This "one-step" 
